Duality announced the appointment of Dr. Yver as Chairman of

PRINCETON, N. J. and SHANGHAI, SUZHOU, China, Oct. 3, 2022 /PRNewswire/ -- Duality Biotherapeutics, Inc. ('Duality' or 'the Company') today announ...

Related Keywords

China , Saclay , France General , France , United States , Shanghai , Paris , Suzhou , Jiangsu , John Zhu , Rhone Poulenc Rorer , Daiichi Sankyo , Antoine Yver , Duality Biotherapeutics Inc , Development At Centessa Pharmaceuticals Ltd , Schering , Astrazeneca , Aventis Group , University Of Paris , Johnson , Antibody Drug Conjugates , Centessa Pharmaceuticals , Executive Vice President , Global Head , Cancer Enterprise , Senior Vice President , Duality Immune Toxin Antibody Conjugate , Translate Novel Modality , First In Class Antibody Drug Conjugate , Antibody Drug Conjugate , Duality Immune Modulating Antibody Conjugate ,